News | Myndsciences

Mynd Life Sciences

MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer&

Acquisition will strengthen MYND’s psilocybin-assisted medicinal and diagnostics capabilities, adding novel psychedelics for the...

Mynd Life Sciences

MYND Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal for $3 Mil

Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression VANCOUVER, BC, Oct. 13, 2021 /CNW/ – MYND...

Mynd Life Sciences

MYND Life Sciences Inc. to Present at Psychedelics Virtual Investor Conference on October 13

VANCOUVER, BC, Oct. 11, 2021 /PRNewswire/ — MYND Life Sciences Inc. (CSE:MYND)(OTC:MYNDF), based in Vancouver BC, focused on novel...